Is Measles IgG Testing for Healthcare Providers Cost-Effective? Results From Seroprevalence Studies of Healthcare Providers in a Tertiary Public Hospital With a Large Foreign-Born Workforce

Infect Control Hosp Epidemiol. 2015 Dec;36(12):1468-71. doi: 10.1017/ice.2015.206. Epub 2015 Sep 2.

Authors

Aidan Lyanzhiang Tan¹, Joanne Yoong², Jareena Kasim³, Grant Ciccone³, Judy Gek Khim Sng², Paul A Tambyah¹

Affiliations

¹ 1Department of Medicine,National University of Singapore,Singapore.
² 2Saw Swee Hock School of Public Health,National University of Singapore,Singapore.
³ 3Department of Medicine,National University of Singapore,Singapore.

PMID: 26329809
DOI: 10.1017/ice.2015.206

No abstract available

MeSH terms

Academic Medical Centers
Cost-Benefit Analysis
Cross Infection / epidemiology*
Cross Infection / virology*
Disease Outbreaks
Emigrants and Immigrants
Health Personnel
Hospitals, Public
Humans
Immunoglobulin G
Measles / blood
Measles / economics
Measles / epidemiology*
Measles / prevention & control
Measles Vaccine / administration & dosage
Measles Vaccine / economics
Measles virus / immunology
Polymerase Chain Reaction
Seroepidemiologic Studies
Singapore / epidemiology

Substances

Immunoglobulin G
Measles Vaccine